BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Liu W, Delwaide J, Bletard N, Delvenne P, Meunier P, Hustinx R, Detry O. 18-Fluoro-deoxyglucose uptake in inflammatory hepatic adenoma: A case report. World J Hepatol 2017; 9(11): 562-566 [PMID: 28469812 DOI: 10.4254/wjh.v9.i11.562]
URL: https://www.wjgnet.com/1007-9327/full/v9/i11/562.htm
Number Citing Articles
1
Javier Villena Salinas, Antonio Jesús Montellano Fenoy, Salomé Sanz Viedma, Miguel Ángel Suárez Muñoz. Steatotic hepatocellular adenoma: an unusual cause of hypermetabolic liver lesionRevista Española de Enfermedades Digestivas 2022;  doi: 10.17235/reed.2022.9026/2022
2
Meghana Prabhu, Averilicia Passah, Vanjul Kansotia, Sandeep Singh. 18-F Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography of a Large Inflammatory-Hepatocellular AdenomaIndian Journal of Nuclear Medicine 2021; 36(1): 95 doi: 10.4103/ijnm.IJNM_87_20
3
Jason R. Young, Rondell P. Graham, Sudhakar K. Venkatesh, Ayse T. Kendi. 18F-FDG PET/CT of hepatocellular adenoma subtypes and review of literatureAbdominal Radiology 2021; 46(6): 2604 doi: 10.1007/s00261-021-02968-2
4
Jason R. Young, Taofic Mounajjed, Rory L. Smoot, Denise M. Harnois, Kaitlyn R. Musto, Sudhakar K. Venkatesh. Evaluation and Management of Liver Masses2020; : 79 doi: 10.1007/978-3-030-46699-2_4
5
Abtin Doroudinia, Mehrdad Bakhshayesh Karam, Niloufar Ghadimi, Farhad Yousefi. Steatotic Hepatitis Presenting as a Huge Hypermetabolic Liver MassClinical Nuclear Medicine 2022; 47(5): e399 doi: 10.1097/RLU.0000000000004098